Primary varicella-zoster infection in patients on biologic therapies for psoriasis.
Hackett
C B
CB
Kirby
B
B
D001691:Biological Therapy; D006562:Herpes Zoster / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D007114:Immunization; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014765:Viral Vaccines / Q000008:administration & dosage
D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D014765:Viral Vaccines